AXL inhibition in treatment-resistant metastatic adenoid cystic carcinoma
Adenoid cystic carcinoma (ACC) presents a formidable challenge due to its slow growth, late-stage metastasis, and resistance to conventional therapies. Targeting the AXL receptor, implicated in aggressive tumor behavior and therapeutic resistance, offers a promising therapeutic avenue. Several studi...
| Published in: | Oral Oncology Reports |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003820 |